EUVIMED · CrossrefZeitschrift
Expert Review of Anti-infective Therapy
ISSN 1478-7210 · Informa UK Limited
Neueste Artikel
Engineering smart liposomes to combat antimicrobial resistance: from mechanistic design to clinical translation
Optimizing colistin dosing in acute-on-chronic liver failure patients with sepsis due to multidrug-resistant Gram-negative pathogens
Perspectives from Taiwan: managing comorbidities amongst the Taiwanese population treating HIV with antiretroviral therapy
Rezafungin in clinical practice: current evidence and expert perspectives
Defining antibiotic use reduction targets for the management of hospital-onset healthcare-associated Clostridioides difficile infection: results of the multi-center TARGET-A project in four UK hospitals
Switching from tenofovir disoproxil fumarate to bictegravir/emtricitabine/ tenofovir alafenamide or non-tenofovir alafenamide regimens: a real-world study of safety and efficacy in Chinese people living with HIV
How have global guidelines advanced the management of cryptococcosis in two years?
Decolonization, containment or source control? Pathogen-specific anti-infective prevention for methicillin-resistant Staphylococcus aureus (MRSA), carbapenem-resistant Enterobacterales (CRE) and Candida auris
The demand-side gap: integrating AWaRe-based antibiotic stewardship into medical education in Pakistan
Emerging therapies against infections due to free-living amoebae
Pan-TB regimens: too good to be true?
HigBA toxin-antitoxin systems in Mycobacterium tuberculosis : stress-responsive regulation, persistence, and therapeutic perspectives
Different problems, different levers: a reply on prioritizing administrative reform of Pakistan’s antibiotic market
Adjunctive infliximab for paradoxical reactions and immune reconstitution inflammatory syndrome in central nervous system tuberculosis: a scoping review
Breakthrough candidemia during prophylactic or empirical antifungal therapy: antifungal exposure, in vitro activity, and association of early treatment modification with mortality
Advances in host-directed therapies for tuberculosis
National trends in antimicrobial consumption in Nepal, 2016–2023: an ecological analysis
Structural determinants of communicable disease risk in asylum reception centers
Evaluating the potential of treatment options for chronic hepatitis B
Novel potential treatment options for infections caused by multi-drug and extensively drug-resistant Neisseria gonorrhoeae strains
Advances in therapeutics and vaccines for Marburg virus disease: challenges and future directions
Evolutionary convergence of enzymatic and target-mediated resistance in Escherichia coli : from CTX-Ms to PBP-3 insertions
The global surge of drug-resistant infections and what it reveals about our failing defenses
Current access, availability and use of antibiotics in primary care among key low- and middle-income countries and the policy implications
Women trailblazers shaping the global future of antimicrobial stewardship and antimicrobial resistance
Overview of novel cefepime-based β-lactam/β-lactamase inhibitor combinations
Metabolic outcomes of bictegravir/emtricitabine/tenofovir alafenamide versus dolutegravir/lamivudine in treatment-naïve people living with HIV: a 48-week retrospective study
Precision antibiotic treatment in intensive care unit-acquired lower respiratory tract infections (ICU-LRTIs): contemporary concepts and future directions
Non-prescription antibiotic dispensing and counseling practices in Iraqi community pharmacies: implications for antimicrobial stewardship and resistance containment
Updates in the clinical management of tuberculous meningitis
EUVIMED